Rare variants in TREM2 strongly increase the likelihood of developing AD, frontotemporal dementia (FTD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) [18–23]. Here, TREM2 is linked to amyotrophic lateral sclerosis.